miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44 - Wu, Shang-Gin; Chang, Tzu-Hua; Tsai, Meng-Feng; Liu, Yi-Nan; Huang, Yen-Lin; Hsu, Chia-Lang; Jheng, Han-Nian; Shih, Jin-Yuan (Molecular therapy. Nucleic acids, 2024)
Keywords: CD44; EGFR; EMT; epidermal growth factor receptor; epithelial-to-mesenchymal transition; miR-204; MT: Noncoding RNAs; Original; osimertinib resistance; stemness; TKI; tyrosine kinase inhibitor; miR-204; TKI; epidermal growth factor receptor; stemness; tyrosine kinase inhibitor; MT: Noncoding RNAs; EMT; CD44; osimertinib resistance; EGFR; epithelial-to-mesenchymal transition